RECRUITING

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriateness, and feasibility/usability of a metastatic breast cancer-specific prognostic tool. These interviews will be conducted by the UNC CHAI Core and will continue until thematic saturation (estimated 10 participants). The investigators will code the qualitative data using emerging themes, guided by a well-established implementation science theory, the Consolidated Framework for Implementation Research (CFIR). The information gained from these studies will inform an implementation approach to increase the usability and acceptability of a novel prognostic tool to assist oncologists in the prognosis of patients with metastatic breast cancer.

Official Title

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

Quick Facts

Study Start:2022-07-15
Study Completion:2025-07-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05440929

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Verbal informed consent obtained to participate in the study.
  2. 2. Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
  3. 3. Physician, nurse practitioner, physician assistant, or nurse navigator
  4. 4. At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.
  1. * Non-English Speaking

Contacts and Locations

Study Contact

Terri Eubanks, BSBA
CONTACT
919-966-4530
teubanks@med.unc.edu
Erin Kelly, MPH, RD, LDN
CONTACT
919-966-0040
erin_kelly@med.unc.edu

Principal Investigator

Emily Ray, MD
PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill

Study Locations (Sites)

University of North Carolina
Chapel Hill, North Carolina, 27599
United States

Collaborators and Investigators

Sponsor: UNC Lineberger Comprehensive Cancer Center

  • Emily Ray, MD, PRINCIPAL_INVESTIGATOR, University of North Carolina, Chapel Hill

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-15
Study Completion Date2025-07-15

Study Record Updates

Study Start Date2022-07-15
Study Completion Date2025-07-15

Terms related to this study

Keywords Provided by Researchers

  • Metastatic Breast Cancer
  • Prognostic Tool
  • End of life
  • Clinicians
  • Prognosis
  • Qualitative Interview
  • Caregivers

Additional Relevant MeSH Terms

  • Metastatic Breast Cancer
  • End of Life